Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |